首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1547295

全球融合活體組織切片市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Fusion Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球融合活體組織切片市場的市場規模將從 2023 年的 6.5256 億美元達到近 14.4681 億美元，2024-2032 年研究期間複合年成長率為 9.25%。

融合活體組織切片用於在活體組織切片手術期間獲得前列腺的詳細 3D 影像。這種方法提高了異常組織區域的可見度，以便將活體組織切片針引入其中。之後，可以採集組織樣本並在顯微鏡下檢查癌症跡象。其他類型的活體組織切片可能會漏掉前列腺癌細胞，但融合活體組織切片可能有助於定位它們。它可以幫助早期發現癌症和製定治療計劃。 MRI 超音波融合導引活體組織切片是該手術的另一個名稱。複雜的磁振造影 (MRI) 掃描與超音波影像相結合，使泌尿科醫生能夠精確定位必須進行準確活體組織切片的前列腺區域。醫生可以使用這種方法對懷疑患有癌症的前列腺的特定大小進行採樣。融合切片檢查依切片途徑可分為兩大類：經會陰切片檢查和經直腸切片檢查。融合活體組織切片的最終用戶包括醫院、診斷機構和門診護理診所。

市場動態

與其他傳統手術如 TRUS 活體組織切片、PSA 測試或直腸指檢等相比，標靶 MR/超音波融合活體組織切片在定義前列腺病變方面具有高靈敏度和特異性，預計將促進市場擴張。融合活體組織切片系統在診斷侵襲性癌症方面的可靠性和可重複性預計將使其成為前列腺活體組織切片的標準工具。由於越來越多的放射科醫生獲得了閱讀前列腺 MRI 的經驗以及 PI-RADS 和 Gleason 評分等標準影像分級方法的部署，因此針對 MR/超音波融合活體組織切片設備的使用已經擴大。各國政府組織對改善醫療基礎設施的日益關注將成為融合活體組織切片市場利潤豐厚的成長動力。此外，對融合活體組織切片領域的投資增加將提供巨大的成長潛力。由於世界各地對定期臨床檢查和可接受的報銷政策的認知不斷提高，融合活體組織切片市場可能會出現有希望的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球融合活體組織切片市場的每個細分市場進行了包容性評估。融合活體組織切片行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

融合活體組織切片市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按路線

經直腸
經會陰

按最終用途

醫院
診斷中心
門診護理中心

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲融合活體組織切片市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。融合切片市場的主要參與者包括 Eigen Health、Koninklijke Philips NV、Hitachi Ltd.、MedCom、ESAOTE SpA、。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：融合切片公司的競爭格局

融合切片市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Eigen Health

公司概況
公司收入
產品
最新動態

Koninklijke Philips NV

公司概況
公司收入
產品
最新動態

Hitachi Ltd.

公司概況
公司收入
產品
最新動態

MedCom

公司概況
公司收入
產品
最新動態

ESAOTE SpA

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216669

The global demand for Fusion Biopsy Market is presumed to reach the market size of nearly USD 1446.81 Million by 2032 from USD 652.56 Million in 2023 with a CAGR of 9.25% under the study period 2024-2032.

A Fusion Biopsy is used to obtain a detailed 3-D image of the prostate during a biopsy surgery. This method improves the visibility of an aberrant tissue area to lead the biopsy needle into it. After that, a sample of tissue can be taken and examined under a microscope for cancer indications. Other types of biopsies may miss prostate cancer cells, but a fusion biopsy may help locate them. It could aid in the early detection of cancer and treatment planning. MRI ultrasound fusion-guided biopsy is another name for this procedure. A sophisticated magnetic resonance imaging (MRI) scan is combined with an ultrasound image to enable urologists to pinpoint the prostate area that must be biopsied accurately. Doctors can use this method to sample the specific size of the prostate where cancer is suspected. The fusion biopsy can be divided into two categories based on the biopsy route: transperineal and transrectal. End-users of fusion biopsy include hospitals, diagnostic facilities, and ambulatory care clinics.

MARKET DYNAMICS

The high sensitivity and specificity of targeted MR/Ultrasound fusion biopsy in defining prostate lesions compared to other traditional procedures like TRUS biopsy, PSA test, or Digital Rectal Examination is expected to promote market expansion. The fusion biopsy system's reliability and reproducibility in diagnosing aggressive cancers are projected to make it a standard tool in prostate biopsy. The use of targeted MR/Ultrasound fusion biopsy devices has expanded due to an increasing number of radiologists obtaining experience in reading prostate MRI and the deployment of standard image grading methods such as PI-RADS and Gleason score. The increasing focus of government organizations in various countries on improving healthcare infrastructure will be a lucrative growth driver for the fusion biopsy market. Additionally, increased investment in the fusion biopsy sector will provide significant growth potential. The fusion biopsy market will likely see promising growth due to increased awareness about regular clinical examinations and acceptable reimbursement policies in various regions worldwide.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fusion Biopsy. The growth and trends of Fusion Biopsy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fusion Biopsy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Route

Transrectal
Transperineal

By End-use

Hospitals
Diagnostic Centers
Ambulatory Care Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fusion Biopsy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fusion Biopsy market include Eigen Health, Koninklijke Philips N.V., Hitachi Ltd., MedCom, ESAOTE SpA, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FUSION BIOPSY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Route
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY ROUTE

5.1. Overview By Route
5.2. Historical and Forecast Data Analysis By Route
5.3. Transrectal Historic and Forecast Sales By Regions
5.4. Transperineal Historic and Forecast Sales By Regions

6. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data Analysis By End-use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Diagnostic Centers Historic and Forecast Sales By Regions
6.5. Ambulatory Care Centers Historic and Forecast Sales By Regions

7. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE FUSION BIOPSY COMPANIES

8.1. Fusion Biopsy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF FUSION BIOPSY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Eigen Health
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Koninklijke Philips N.V.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Hitachi Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. MedCom
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. ESAOTE SpA
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments